These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1660046

  • 1. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
    Cooper MA, Andrews JM, Wise R.
    J Antimicrob Chemother; 1991 Sep; 28(3):399-405. PubMed ID: 1660046
    [Abstract] [Full Text] [Related]

  • 2. Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
    Borobio MV, Conejo M, Ramirez E, Suarez AI, Perea EJ.
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1442-5. PubMed ID: 8092852
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.
    Zabinski RA, Vance-Bryan K, Krinke AJ, Walker KJ, Moody JA, Rotschafer JC.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2454-8. PubMed ID: 8285633
    [Abstract] [Full Text] [Related]

  • 4. Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes.
    Spangler SK, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():23-7. PubMed ID: 9222066
    [Abstract] [Full Text] [Related]

  • 5. Absence of bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
    Morrissey I, Smith JT.
    J Antimicrob Chemother; 1992 May; 29(5):589-90. PubMed ID: 1320605
    [No Abstract] [Full Text] [Related]

  • 6. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.
    Brook I.
    Antimicrob Agents Chemother; 1993 May; 37(5):997-1000. PubMed ID: 8517727
    [Abstract] [Full Text] [Related]

  • 7. Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure.
    Peterson ML, Hovde LB, Wright DH, Hoang AD, Raddatz JK, Boysen PJ, Rotschafer JC.
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2251-5. PubMed ID: 10471574
    [Abstract] [Full Text] [Related]

  • 8. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
    Goldstein EJ, Citron DM.
    Antimicrob Agents Chemother; 1992 May; 36(5):1158-62. PubMed ID: 1324640
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin- resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique.
    Stearne LE, Kooi C, Goessens WH, Bakker-Woudenberg IA, Gyssens IC.
    Antimicrob Agents Chemother; 2001 Jan; 45(1):243-51. PubMed ID: 11120973
    [Abstract] [Full Text] [Related]

  • 10. Effect of anaerobic growth on quinolone lethality with Escherichia coli.
    Malik M, Hussain S, Drlica K.
    Antimicrob Agents Chemother; 2007 Jan; 51(1):28-34. PubMed ID: 17043118
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of anaerobic bacteria to PD 131628.
    Nord CE, Hagelbäck A.
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):68-71. PubMed ID: 1314176
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin against Escherichia coli strains isolated from diarrheic lambs and kids.
    Cid D, Piriz S, Ruiz-Santa-Quiteria JA, Valle J, Garcia S, Vadillo S, de la Fuente R.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2469-70. PubMed ID: 7840590
    [Abstract] [Full Text] [Related]

  • 13. [Bactericidal activity of Trovafloxacin and Moxifloxacin against Gram-negative anaerobic bacilli].
    Bosnea D, Stadoleanu C, Boswell FJ, Buiuc D.
    Rev Med Chir Soc Med Nat Iasi; 2000 Oct; 104(4):117-22. PubMed ID: 12089939
    [Abstract] [Full Text] [Related]

  • 14. Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones.
    Zabinski RA, Walker KJ, Larsson AJ, Moody JA, Kaatz GW, Rotschafer JC.
    Antimicrob Agents Chemother; 1995 Feb; 39(2):507-12. PubMed ID: 7726522
    [Abstract] [Full Text] [Related]

  • 15. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.
    Oh H, El Amin N, Davies T, Appelbaum PC, Edlund C.
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1977-81. PubMed ID: 11408211
    [Abstract] [Full Text] [Related]

  • 16. [Bactericidal activity of ciprofloxacin and sparfloxacin. Comparison with others active antibiotics against Pasteurella multocida].
    Gastine C, Donnio PY, Travert MF, Avril JL.
    Presse Med; 1995 Mar 18; 24(11):519-22. PubMed ID: 7770389
    [Abstract] [Full Text] [Related]

  • 17. The bactericidal activity of sparfloxacin.
    Lewin CS, Morrissey I, Smith JT.
    J Antimicrob Chemother; 1992 Nov 18; 30(5):625-32. PubMed ID: 1337350
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo antibacterial activities of AM-1155 in the fields of obstetrics and gynecology.
    Mikamo H, Kawazoe K, Sato Y, Hayasaki Y, Izumi K, Tamaya T.
    Chemotherapy; 1998 Nov 18; 44(4):238-42. PubMed ID: 9681200
    [Abstract] [Full Text] [Related]

  • 19. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Aldridge KE.
    Antimicrob Agents Chemother; 1994 Jul 18; 38(7):1671-4. PubMed ID: 7979307
    [Abstract] [Full Text] [Related]

  • 20. Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method.
    Tanaka M, Hoshino K, Hohmura M, Ishida H, Kitamura A, Sato K, Hayakawa I, Nishino T.
    J Antimicrob Chemother; 1996 Jun 18; 37(6):1091-102. PubMed ID: 8836812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.